Gilead Sciences - 27 Year Stock Price History | GILD

Historical daily share price chart and data for Gilead Sciences since 1992 adjusted for splits. The latest closing stock price for Gilead Sciences as of December 11, 2019 is 67.78.
  • The all-time high Gilead Sciences stock closing price was 122.21 on June 23, 2015.
  • The Gilead Sciences 52-week high stock price is 70.50, which is 4% above the current share price.
  • The Gilead Sciences 52-week low stock price is 60.32, which is 11% below the current share price.
  • The average Gilead Sciences stock price for the last 52 weeks is 65.56.
Gilead Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 65.6528 63.4400 70.0500 61.6200 67.7800 8.36%
2018 73.8243 74.1000 88.8000 60.5400 62.5500 -12.69%
2017 72.3252 74.1600 85.4700 64.1200 71.6400 0.04%
2016 83.5809 98.0100 102.2900 71.6100 71.6100 -29.23%
2015 106.5288 94.9100 122.2100 94.8000 101.1900 7.35%
2014 89.5787 75.2100 114.2200 65.4800 94.2600 25.51%
2013 56.0605 37.5300 75.2000 37.4750 75.1000 104.49%
2012 28.2605 20.9300 38.1700 20.9300 36.7250 79.45%
2011 19.9639 18.2900 21.6050 17.6700 20.4650 12.94%
2010 19.6352 21.6500 24.7250 15.9150 18.1200 -16.25%
2009 23.0576 26.0900 26.4000 20.7200 21.6350 -15.39%
2008 24.5922 22.6700 28.5500 18.7350 25.5700 11.15%
2007 19.7900 15.7875 23.8700 15.6825 23.0050 41.72%
2006 15.4776 13.6750 17.4375 13.4375 16.2325 23.51%
2005 10.5689 8.6825 13.9075 7.7600 13.1425 50.24%
2004 8.0435 7.2525 9.7600 6.4700 8.7475 20.08%
2003 6.4362 4.3613 8.7488 4.0375 7.2850 71.41%
2002 4.2569 3.8394 4.9638 3.3188 4.2500 3.47%
2001 3.1340 2.3166 4.5131 1.6894 4.1075 58.47%
2000 2.3545 1.7597 3.6313 1.3575 2.5919 53.22%
1999 1.6682 1.2422 2.8869 1.1172 1.6916 31.84%
1998 0.9967 1.1916 1.3516 0.5703 1.2831 7.35%
1997 0.9798 0.7656 1.4416 0.6759 1.1953 52.99%
1996 0.8862 1.0194 1.2734 0.5391 0.7813 -21.87%
1995 0.5761 0.2930 1.0078 0.2930 1.0000 236.81%
1994 0.3143 0.3750 0.4375 0.2188 0.2969 -20.83%
1993 0.4623 0.5703 0.5978 0.3359 0.3750 -37.67%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $84.676B $22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.338B 15.94
CSL (CSLLY) Australia $86.171B 0.00
Vertex Pharmaceuticals (VRTX) United States $56.411B 57.58
Biogen (BIIB) United States $53.330B 9.15
Illumina (ILMN) United States $48.009B 52.68
Regeneron Pharmaceuticals (REGN) United States $40.144B 17.58
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.891B 12.29
Incyte (INCY) United States $20.418B 47.40
Seattle Genetics (SGEN) United States $19.560B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.114B 0.00
Genmab (GNMSF) Denmark $14.371B 63.48
BioMarin Pharmaceutical (BMRN) United States $14.172B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.458B 0.00
Galapagos (GLPG) Belgium $11.831B 30.48
Exact Sciences (EXAS) United States $10.931B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
QIAGEN (QGEN) Netherlands $9.363B 30.53
BeiGene (BGNE) Cayman Islands $8.766B 0.00
Bio-Techne Corp (TECH) United States $8.356B 55.93
Amarin (AMRN) Ireland $8.062B 0.00
Sarepta Therapeutics (SRPT) United States $7.883B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.382B 0.00
Guardant Health (GH) United States $6.775B 0.00
Medicines (MDCO) United States $6.709B 0.00
BioNTech SE (BNTX) Germany $6.562B 0.00
Moderna (MRNA) United States $6.258B 0.00
Reata Pharmaceuticals (RETA) United States $6.139B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.973B 15.19
ARGENX SE-ADR (ARGX) Netherlands $5.822B 0.00
Exelixis (EXEL) United States $5.114B 14.39
Repligen (RGEN) United States $4.699B 85.16
China Biologic Products (CBPO) China $4.611B 25.97
Ascendis Pharma (ASND) Denmark $4.463B 0.00
Spark Therapeutics (ONCE) United States $4.281B 0.00
MorphoSys AG (MOR) Germany $4.273B 0.00
Bluebird Bio (BLUE) United States $4.238B 0.00
Mirati Therapeutics (MRTX) United States $4.100B 0.00
Immunomedics (IMMU) United States $4.037B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.724B 0.00
Adaptive Biotechnologies (ADPT) United States $3.642B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.629B 0.00
Blueprint Medicines (BPMC) United States $3.462B 0.00
Alkermes (ALKS) Ireland $3.425B 0.00
MyoKardia (MYOK) United States $3.096B 0.00
Genmab (GMAB) Denmark $3.091B 6.37
Halozyme Therapeutics (HALO) United States $2.789B 0.00
Emergent Biosolutions (EBS) United States $2.787B 27.69
UniQure (QURE) Netherlands $2.748B 0.00
NeoGenomics (NEO) United States $2.711B 144.28
Acceleron Pharma (XLRN) United States $2.650B 0.00
Amicus Therapeutics (FOLD) United States $2.487B 0.00
Arena Pharmaceuticals (ARNA) United States $2.451B 5.70
Zai Lab (ZLAB) China $2.446B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.399B 0.00
RA PHARMCTL INC (RARX) United States $2.221B 0.00
Insmed (INSM) United States $2.047B 0.00
Myriad Genetics (MYGN) United States $1.861B 27.50
Ligand Pharmaceuticals (LGND) United States $1.858B 35.74
Momenta Pharmaceuticals (MNTA) United States $1.769B 0.00
Denali Therapeutics (DNLI) United States $1.753B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.742B 0.00
Epizyme (EPZM) United States $1.693B 0.00
Akcea Therapeutics (AKCA) United States $1.661B 0.00
REGENXBIO (RGNX) United States $1.572B 0.00
Zymeworks (ZYME) Canada $1.562B 0.00
Editas Medicine (EDIT) United States $1.556B 0.00
Fate Therapeutics (FATE) United States $1.460B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.434B 0.00
Principia Biopharma (PRNB) United States $1.376B 0.00
Alector (ALEC) United States $1.353B 0.00
Innoviva (INVA) United States $1.347B 3.97
Arvinas (ARVN) United States $1.312B 0.00
Athenex (ATNX) United States $1.291B 0.00
Coherus BioSciences (CHRS) United States $1.232B 0.00
Sangamo Therapeutics (SGMO) United States $1.195B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
WAVE Life Sciences (WVE) Singapore $1.112B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.079B 0.00
Zealand Pharma (ZEAL) Denmark $0.974B 0.00
Pharming Group (PHGUF) Netherlands $0.967B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.943B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.928B 7.80
Codexis (CDXS) United States $0.913B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.870B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.846B 0.00
Vericel (VCEL) United States $0.827B 308.33
Intellia Therapeutics (NTLA) United States $0.817B 0.00
MiMedx (MDXG) United States $0.808B 0.00
Twist Bioscience (TWST) United States $0.806B 0.00
Anika Therapeutics (ANIK) United States $0.793B 25.71
ANI Pharmaceuticals (ANIP) United States $0.738B 12.59
Heska (HSKA) United States $0.732B 187.08
Revance Therapeutics (RVNC) United States $0.731B 0.00
Adverum Biotechnologies (ADVM) United States $0.722B 0.00
UROGEN PHARMA (URGN) United States $0.719B 0.00
DBV Technologies S.A (DBVT) France $0.718B 0.00
Cara Therapeutics (CARA) United States $0.651B 0.00
Mesoblast (MESO) Australia $0.648B 0.00
Intra-Cellular Therapies (ITCI) United States $0.638B 0.00
Cellectis S.A (CLLS) France $0.632B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.630B 0.00
Sorrento Therapeutics (SRNE) United States $0.627B 0.00
Kadmon Holdings (KDMN) United States $0.594B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
Clovis Oncology (CLVS) United States $0.587B 0.00
AC Immune SA (ACIU) Switzerland $0.586B 13.55
GENFIT S.A (GNFT) France $0.583B 0.00
PHARMA MAR SA (PHMMF) Spain $0.580B 0.00
Retrophin (RTRX) United States $0.572B 0.00
BioDelivery Sciences (BDSI) United States $0.572B 0.00
Cytokineticsorporated (CYTK) United States $0.569B 0.00
Dynavax Technologies (DVAX) United States $0.553B 0.00
Agenus (AGEN) United States $0.537B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.529B 3.66
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Prothena (PRTA) Ireland $0.510B 0.00
Stemline Therapeutics (STML) United States $0.497B 0.00
Precision BioSciences (DTIL) United States $0.482B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
PDL BioPharma (PDLI) United States $0.410B 10.27
Bellus Health (BLU) Canada $0.386B 0.00
Merus (MRUS) Netherlands $0.383B 0.00
Arcus Biosciences (RCUS) United States $0.375B 0.00
AnaptysBio (ANAB) United States $0.374B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.365B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.359B 0.00
OSMOTICA PHARM (OSMT) United States $0.347B 0.00
Pfenex (PFNX) United States $0.332B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
Gritstone Oncology (GRTS) United States $0.330B 0.00
Avid Bioservices (CDMO) United States $0.329B 0.00
Starpharma Holdings (SPHRY) Australia $0.311B 0.00
Kamada (KMDA) Israel $0.310B 9.06
Geron (GERN) United States $0.306B 0.00
Kindred Biosciences (KIN) United States $0.304B 0.00
Puma Biotechnology (PBYI) United States $0.299B 0.00
CytomX Therapeutics (CTMX) United States $0.289B 0.00
Compugen (CGEN) Israel $0.279B 0.00
Cel-Sci (CVM) United States $0.269B 0.00
Cue Biopharma (CUE) United States $0.268B 0.00
Seres Therapeutics (MCRB) United States $0.266B 0.00
Scholar Rock Holding (SRRK) United States $0.260B 0.00
Albireo Pharma (ALBO) United States $0.258B 0.00
MannKind (MNKD) United States $0.252B 0.00
ADMA Biologics Inc (ADMA) United States $0.246B 0.00
Inovio Pharmaceuticals (INO) United States $0.246B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.241B 0.00
Theratechnologies (THTX) Canada $0.236B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
Sutro Biopharma (STRO) United States $0.236B 0.00
ChromaDex (CDXC) United States $0.229B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Biofrontera AG (BFRA) Germany $0.221B 0.00
Exicure (XCUR) United States $0.220B 0.00
XOMA (XOMA) United States $0.218B 0.00
Senesco Technologies (ELOX) United States $0.218B 0.00
IVERIC Bio (ISEE) United States $0.217B 0.00
Spero Therapeutics (SPRO) United States $0.217B 0.00
Protagonist Therapeutics (PTGX) United States $0.208B 0.00
Athersys (ATHX) United States $0.205B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Mersana Therapeutics (MRSN) United States $0.203B 0.00
Syros Pharmaceuticals (SYRS) United States $0.192B 0.00
Palatin Technologies (PTN) United States $0.182B 4.96
Proteostasis Therapeutics (PTI) United States $0.180B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.179B 0.00
Affimed (AFMD) Germany $0.172B 0.00
NantKwest (NK) United States $0.165B 0.00
ARAVIVE, INC (ARAV) United States $0.165B 0.00
Cerecor (CERC) United States $0.164B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.160B 0.00
Dyadic (DYAI) United States $0.160B 0.00
Alcobra (ARCT) United States $0.159B 0.00
CorMedix Inc (CRMD) United States $0.159B 0.00
VBI Vaccines (VBIV) United States $0.156B 0.00
Abeona Therapeutics (ABEO) United States $0.150B 0.00
Arsanis (XFOR) United States $0.150B 0.00
Five Prime Therapeutics (FPRX) United States $0.142B 0.00
Aptinyx (APTX) United States $0.137B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.137B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.136B 0.00
Arbutus Biopharma (ABUS) Canada $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
TELA Bio (TELA) United States $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Prometic Life Sciences (LMNL) Canada $0.132B 0.00
Nicox SA (NICXF) France $0.126B 0.00
Enzo Biochem (ENZ) United States $0.125B 0.00
Fortress Biotech (FBIO) United States $0.123B 0.00
SESEN BIO, INC (SESN) United States $0.122B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.119B 0.00
Windtree Therapeutics (WINT) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.118B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.115B 0.00
BioTime (LCTX) United States $0.111B 5.72
Novavax (NVAX) United States $0.111B 0.00
Menlo Therapeutics (MNLO) United States $0.108B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.102B 0.00
Verastem (VSTM) United States $0.102B 0.00
Strongbridge Biopharma (SBBP) United States $0.096B 2.57
Aduro Biotech (ADRO) United States $0.095B 0.00
PHASEBIO PHARMA (PHAS) United States $0.092B 0.00
Antibe Therapeutics (ATBPF) Canada $0.090B 0.00
Emmaus Life Sciences (EMMA) United States $0.090B 0.00
Adocia (ADOCY) France $0.086B 0.00
OvaScience (MLND) United States $0.085B 0.00
Acorda Therapeutics (ACOR) United States $0.083B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Synlogic (SYBX) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.077B 0.00
Selecta Biosciences (SELB) United States $0.075B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.075B 0.00
Liquidia Technologies (LQDA) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.067B 0.00
Trevena (TRVN) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.064B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.058B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.051B 0.00
Curis (CRIS) United States $0.050B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
Checkpoint Therapeutics (CKPT) United States $0.048B 0.00
Protalix BioTherapeutics (PLX) Israel $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
Alimera Sciences (ALIM) United States $0.045B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Orgenesis (ORGS) United States $0.042B 2.71
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Apricus Biosciences (SEEL) United States $0.038B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Stellar Biotechnologies (EDSA) Canada $0.034B 0.00
Evogene (EVGN) Israel $0.033B 0.00
Celsion (CLSN) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.033B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
Bionano Genomics (BNGO) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Novogen (KZIA) Australia $0.027B 0.00
BioCardia (BCDA) United States $0.026B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.026B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Soligenix (SNGX) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.020B 0.00
Signal Genetics (MGEN) United States $0.019B 0.00
VistaGen Therapeutics (VTGN) United States $0.019B 0.00
Unum Therapeutics (UMRX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Advaxis (ADXS) United States $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.012B 0.00
TrovaGene (TROV) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
IBio (IBIO) United States $0.009B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00